Literature DB >> 10147228

Expanding the role of pharmacists in pharmacoeconomics: why and how?

L A Sanchez1.   

Abstract

Mesh:

Year:  1994        PMID: 10147228     DOI: 10.2165/00019053-199405050-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  10 in total

Review 1.  Pharmacoeconomics of genetically engineered drugs.

Authors:  A J Jones-Grizzle; J L Bootman
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

2.  Principles of pharmacoeconomic analysis of drug therapy.

Authors:  D A Freund; R S Dittus
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

3.  The changing healthcare environment: socioeconomic evaluation of drug therapy.

Authors:  D B Evans
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

4.  Quality of life assessment: understanding its use as an outcome measure.

Authors:  S J Coons; R M Kaplan
Journal:  Hosp Formul       Date:  1993-05

5.  Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.

Authors:  W F McGhan
Journal:  Hosp Formul       Date:  1993-04

6.  Guidelines for performing a pharmacoeconomic analysis.

Authors:  L M Jolicoeur; A J Jones-Grizzle; J G Boyer
Journal:  Am J Hosp Pharm       Date:  1992-07

Review 7.  Interpretation of "cost-effective" and soundness of economic evaluations in the pharmacy literature.

Authors:  J T Lee; L A Sanchez
Journal:  Am J Hosp Pharm       Date:  1991-12

8.  Use and misuse of the term "cost effective" in medicine.

Authors:  P Doubilet; M C Weinstein; B J McNeil
Journal:  N Engl J Med       Date:  1986-01-23       Impact factor: 91.245

Review 9.  Quality of life instruments in the evaluation of new drugs.

Authors:  R Jaeschke; G H Guyatt; D Cook
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

10.  Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a cost-benefit analysis.

Authors:  C J Destache; S K Meyer; M J Bittner; K G Hermann
Journal:  Ther Drug Monit       Date:  1990-09       Impact factor: 3.681

  10 in total
  1 in total

1.  Pharmacoeconomics and formulary decision making.

Authors:  L A Sanchez
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.